Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TERIKIDS pediatric relapsing multiple sclerosis trial of teriflunomide versus placebo
MOH_2017-02-28_000185Phase 3Active, not recruiting
- Sponsor
- Sanofi
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Aubagio with Placebo (2 arms). Primary endpoint: Primary efficacy and safety assessment. Started Jul 2015; status: active, not recruiting.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on MOH_2017-02-28_000185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-02-28_000185.